Najar Hatem, Tuider Laurene, Kukkar Vinita, Quasem Mohammad
Internal Medicine Department, United Health Services Hospitals, Johnson City, USA.
Pathology Department, United Health Services Hospitals, Johnson City, USA.
Cureus. 2022 Apr 17;14(4):e24221. doi: 10.7759/cureus.24221. eCollection 2022 Apr.
Thrombotic microangiopathy (TMA) is a serious and potentially fatal disorder, especially if there is a delay in diagnosis and appropriate treatment. Thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS) are the two main forms of TMA. Although severe acute kidney injury (AKI) is a common manifestation of TMA, it remains rarely described in reported TTP cases. We present a rare case of TTP in a 76-year-old African American male who presented with severe AKI (stage 3) and uremic symptoms. Early diagnosis and prompt treatment of TTP with plasmapheresis followed by rituximab and caplacizumab were associated with the resolution of the AKI and avoidance of hemodialysis. This case highlights the need to consider TTP as a possible diagnosis even in the setting of severe AKI.
血栓性微血管病(TMA)是一种严重且可能致命的疾病,尤其是在诊断和适当治疗出现延迟的情况下。血栓性血小板减少性紫癜(TTP)和溶血性尿毒症综合征(HUS)是TMA的两种主要形式。虽然严重急性肾损伤(AKI)是TMA的常见表现,但在已报道的TTP病例中仍很少被描述。我们报告了一例罕见的TTP病例,患者为一名76岁的非裔美国男性,表现为严重AKI(3期)和尿毒症症状。早期诊断并及时用血浆置换治疗TTP,随后使用利妥昔单抗和卡泊单抗,使AKI得到缓解并避免了血液透析。该病例强调,即使在严重AKI的情况下,也需要考虑TTP作为一种可能的诊断。